Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.

Marrero-Santos KM, Beltrán M, Carrión-Lebrón J, Sanchez-Vegas C, Hamer DH, Barnett ED, Santiago LM, Hunsperger EA.

Clin Vaccine Immunol. 2013 Mar;20(3):358-62. doi: 10.1128/CVI.00429-12. Epub 2013 Jan 9.

2.

Prevalence of dengue virus infection in US travelers who have lived in or traveled to dengue-endemic countries.

Sanchez-Vegas C, Hamer DH, Chen LH, Wilson ME, Benoit C, Hunsperger E, Macleod WB, Jentes ES, Ooi WW, Karchmer AW, Kogelman L, Yanni E, Marano N, Barnett ED.

J Travel Med. 2013 Nov-Dec;20(6):352-60. doi: 10.1111/jtm.12057. Epub 2013 Aug 16.

3.

[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].

Ergünay K, Saygan MB, Aydoğan S, Litzba N, Niedrig M, Pınar A, Us D.

Mikrobiyol Bul. 2010 Jul;44(3):415-24. Turkish.

PMID:
21063991
4.

Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection.

Rocha ES, Oliveira JG, Santos JR, Rodrigues GO, Figueiredo LB, Pessanha JE, Proietti FA, Fonseca FG, Bonjardim CA, Ferreira PC, Kroon EG.

J Virol Methods. 2013 Jan;187(1):114-20. doi: 10.1016/j.jviromet.2012.09.012. Epub 2012 Sep 24.

5.

Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset.

Cucunawangsih, Lugito NP, Kurniawan A.

BMC Infect Dis. 2015 Jul 21;15:276. doi: 10.1186/s12879-015-1022-9.

6.

[Flavivirus seroepidemiology in blood donors in Mersin province, Turkey].

Tezcan S, Kızıldamar S, Ulger M, Aslan G, Tiftik N, Ozkul A, Emekdaş G, Niedrig M, Ergünay K.

Mikrobiyol Bul. 2014 Oct;48(4):606-17. Turkish.

7.

Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers.

Schwartz E, Mileguir F, Grossman Z, Mendelson E.

J Clin Virol. 2000 Dec;19(3):169-73.

PMID:
11090753
8.

[Establishment and preliminary application of dengue virus envelope domain III IgG antibody capture enzyme-linked immuno-absorbent assay].

Hu DM, Cai JP, Wang DH, DI B, Qiu LW, Wang YD, Chen Y, Ding XX, Che XY.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Apr;47(4):363-6. Chinese.

PMID:
23928645
9.

Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas.

Olivero RM, Hamer DH, MacLeod WB, Benoit CM, Sanchez-Vegas C, Jentes ES, Chen LH, Wilson ME, Marano N, Yanni EA, Ooi WW, Karchmer AW, Kogelman L, Barnett ED.

Am J Trop Med Hyg. 2016 Aug 29. pii: 16-0159. [Epub ahead of print]

PMID:
27573631
10.

Dengue virus seroprevalence among febrile patients in Bamako, Mali: results of a 2006 surveillance study.

Phoutrides EK, Coulibaly MB, George CM, Sacko A, Traore S, Bessoff K, Wiley MR, Kolivras KN, Adelman Z, Traore M, Hunsperger EA.

Vector Borne Zoonotic Dis. 2011 Nov;11(11):1479-85. doi: 10.1089/vbz.2011.0622. Epub 2011 Jul 18.

PMID:
21767159
11.

Diagnosis of dengue fever in North West Italy in travelers from endemic areas: a retrospective study.

Burdino E, Milia MG, Sergi G, Gregori G, Allice T, Cazzato ML, Lucchini A, Lipani F, Calleri G, Orofino G, Di Perri G, Ghisetti V.

J Clin Virol. 2011 Aug;51(4):259-63. doi: 10.1016/j.jcv.2011.05.011. Epub 2011 Jun 1.

PMID:
21636317
12.

Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus.

Niedrig M, Kürsteiner O, Herzog C, Sonnenberg K.

Clin Vaccine Immunol. 2008 Feb;15(2):177-81. Epub 2007 Nov 28.

13.

Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot.

Cuzzubbo AJ, Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Aaskov J, Dung NM, Devine PL.

J Clin Virol. 2000 Apr;16(2):135-44.

PMID:
10720818
15.

Dengue virus antibodies in blood donors from an endemic area.

Rodríguez Rodríguez D, Garza Rodríguez M, Chavarria AM, Ramos-Jiménez J, Rivera MA, Taméz RC, Farfan-Ale J, Rivas-Estilla AM.

Transfus Med. 2009 Jun;19(3):125-31. doi: 10.1111/j.1365-3148.2009.00922.x.

PMID:
19566669
16.

Approach to non-invasive sampling in dengue diagnostics: exploring virus and NS1 antigen detection in saliva and urine of travelers with dengue.

Korhonen EM, Huhtamo E, Virtala AM, Kantele A, Vapalahti O.

J Clin Virol. 2014 Nov;61(3):353-8. doi: 10.1016/j.jcv.2014.08.021. Epub 2014 Sep 1.

PMID:
25242312
17.

Comparison of PanBio dengue duo enzyme-linked immunosorbent assay (ELISA) and MRL dengue fever virus immunoglobulin M capture ELISA for diagnosis of dengue virus infections in Southeast Asia.

Cuzzubbo AJ, Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Aaskov J, Dung NM, Devine PL.

Clin Diagn Lab Immunol. 1999 Sep;6(5):705-12.

18.

Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections.

Libraty DH, Zhang L, Obcena A, Brion JD, Capeding RZ.

Acta Trop. 2015 Feb;142:103-7. doi: 10.1016/j.actatropica.2014.11.009. Epub 2014 Nov 25.

19.

Multicountry prospective clinical evaluation of two enzyme-linked immunosorbent assays and two rapid diagnostic tests for diagnosing dengue fever.

Pal S, Dauner AL, Valks A, Forshey BM, Long KC, Thaisomboonsuk B, Sierra G, Picos V, Talmage S, Morrison AC, Halsey ES, Comach G, Yasuda C, Loeffelholz M, Jarman RG, Fernandez S, An US, Kochel TJ, Jasper LE, Wu SJ.

J Clin Microbiol. 2015 Apr;53(4):1092-102. doi: 10.1128/JCM.03042-14. Epub 2015 Jan 14.

20.

Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.

Hertz JT, Munishi OM, Ooi EE, Howe S, Lim WY, Chow A, Morrissey AB, Bartlett JA, Onyango JJ, Maro VP, Kinabo GD, Saganda W, Gubler DJ, Crump JA.

Am J Trop Med Hyg. 2012 Jan;86(1):171-7. doi: 10.4269/ajtmh.2012.11-0393.

Items per page

Supplemental Content

Write to the Help Desk